In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
said during the advisory committee meeting in September. "Design a real study, do a real study, then we can talk about the ...
The U.S. Food and Drug Administration's ("FDA") new advisory committee on digital health is set to examine its approach for evaluating and ...
On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...
FDA officials said an agency review of the available data found oral phenylephrine is not effective as a nasal decongestant ...
Intercept Pharmaceuticals, now wholly owned subsidiary of Italy’s Alfasigma, today revealed that the US Food and Drug ...
A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...